The global regenerative market is estimated to reach USD 67.6 billion by 2019, from USD 16.4 billion in 2014, growing at a CAGR of 23.2 %. Small molecules and biologics show immense potential in the market and are estimated to grow at a CAGR of 18.9%.Regenerative medicines have the ability to restore the lost functionality of tissues or organs, unlike conventional medicines which are palliative.
There are several factors driving and restraining the global regenerative medicines market. Some of these are listed below.
Technological innovations in stem cell therapy and tissue engineering
Growing prevalence of bone and joint diseases
Growing need of orthopedic surgeries
Advancements in nanotechnology
Increased in innovation in stem cell therapy
Rules laid down by regulatory bodies
Ethical issues related to regenerative medicines
Cost of the treatment.
The market is segmented on the basis of technology, applications, and geography.
By technology, the market is divided into stem cell therapy, biomaterial, and tissue engineering.
By type of applications, the market is segmented into bone graft substitutes, osteoarticular diseases, central nervous system and cardiovascular.
By geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World.
North America and Europe account for more than three-fourths of the revenue in 2013. However, technological advancement and research emphasis are growing in the Asia-Pacific region, so this is going to be a potential market for regenerative medicines.
Some of the key players in the market are:
Anika Therapeutics, Inc.
Baxter International, Inc.
DePuy Synthes, Inc.
What the Report Offers
A wide and in-depth analysis of the market share and market size estimation based on products, applications, and services.
High-level analysis of the competitive landscape, which in turn includes mergers & acquisitions, collaborations, new product launches and new strategies which major players are following to keep pace with the market.
Market analysis for the regenerative medicine market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Identification and analysis of the macro and micro factors that affect the market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions where this industry is blooming and to also identify the regions that are still untapped.
Manager – Partner Relations & International Marketing
Ph: +1-214-377-1121 (US)/ +44-020-3286-9338 (UK)